InterCure (NASDAQ:INCR) & Jushi (OTCMKTS:JUSHF) Financial Analysis

Jushi (OTCMKTS:JUSHF) and InterCure (NASDAQ:INCR) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Institutional and Insider Ownership

21.7% of Jushi shares are owned by institutional investors. Comparatively, 8.3% of InterCure shares are owned by institutional investors. 22.5% of Jushi shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Jushi and InterCure’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jushi	-25.15%	N/A	-15.07%
InterCure	N/A	N/A	N/A

Volatility & Risk

Jushi has a beta of -0.86, suggesting that its share price is 186% less volatile than the S&P 500. Comparatively, InterCure has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500.

Valuation and Earnings

This table compares Jushi and InterCure”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jushi	$257.52 million	0.56	-$48.78 million	($0.33)	-2.21
InterCure	$64.55 million	N/A	-$18.32 million	$0.13	10.77

InterCure has lower revenue, but higher earnings than Jushi. Jushi is trading at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Jushi and InterCure, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jushi	0	0	0	1	4.00
InterCure	1	0	0	0	1.00

Summary

InterCure beats Jushi on 6 of the 11 factors compared between the two stocks.

About Jushi

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature’s Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.